Menu
Not yet recruiting NCT06689631

Mucociliary Clearance Techniques for Acute Bronchiolitis

No phase Interventional Acute Bronchiolitis Due to Respiratory Syncytial Virus Bronchiolitis Acute Bronchiolitis Acute Viral

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Respiratory Physiotherapy.
Who it may be relevant to
Registry conditions: Acute Bronchiolitis Due to Respiratory Syncytial Virus, Bronchiolitis Acute, Bronchiolitis Acute Viral. Basic parameters: 28 Days — 12 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Efficacy of Mucociliary Clearance Techniques in Non-hospitalised Infants with Acute Bronchiolitis

Overview

To assess the efficacy of mucociliary clearance techniques in non-hospitalised infants with a first episode of mild to moderate acute bronchiolitis.

Interventions

  • Procedure Respiratory Physiotherapy
    Mucociliary clearance techniques (prolonged slow expiration and provoked cough), bronchodilator when prescribed and nebulisation with 3% hypertonic saline.

Primary outcome measures

  • ESBA [Time frame: 1 session (45 minutes)]

Eligibility criteria

Inclusion criteria

  • Medical diagnosis of first episode of acute Bronchiolitis.
  • Acute Bronchiolitis with mild (ESBA score = 1-4) or moderate (ESBA score =5-9) severity according to the ESBA.
  • Informed consent signed by parents or legal guardians.

Exclusion criteria

  • Infants previously diagnosed with chronic respiratory disease.
  • Previous episodes of wheezing.
  • Presence of any type of contraindication to receive Respiratory Physiotherapy treatment.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Gonzalez Bellido V, Velaz Baza V, Esteo MDCJ, Carballo RG, Colombo A, Zaldivar JNC, Donadio MVF. Safety of airway clearance combined with bronchodilator and hypertonic saline in non-hospitalized infants with acute bronchiolitis. Arch Pediatr. 2021 Nov;28(8):707-711. doi: 10.1016/j.arcped.2021.09.007. Epub 2021 Oct 5. PMID 34625378

Identifiers

NCT: NCT06689631 · ETICA-ULE-062-2023 · ULE

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗